Immune cells’ ability to degrade amyloid-beta peptides restored in mice treated with lithium salt
Lithium deficiency in the brain could be an underlying contributor to Alzheimer’s disease, according to new research led by scientists at Harvard Medical School in Boston, US. The findings suggest that it may be possible in future to stall or reverse the disease by administering lithium, though this has not yet been shown in patients.